The present invention provides a compound of formula (I) wherein R1-R5, R25, R26, Y and X2 are defined as in claim 1. The compounds activate human peroxisome proliferator activated receptors (hPPARs) and are useful for the treatment of associated disorders such as cardiovascular disease and hypercholesteremia.
本发明提供了式(I)的化合物,其中R1-R5,R25,R26,Y和X2如权利要求1所定义。这些化合物可以激活人类
过氧化物酶体增殖物激活受体(h
PPARs),并且适用于治疗相关疾病,例如心血管疾病和高
胆固醇血症。